About Us

Text-Size:A A A+

The nationwide law firm of Bernstein Liebhard LLP is actively monitoring updates in the numerous federal and state litigations involving defective drugs and medical devices in the U.S. In particular, the Firm’s attorneys are actively filing lawsuits in proceedings that involve diabetes-treating and antipsychotic medications, metal hip replacement devices, transvaginal mesh implants and even a remote-controlled surgery robot, to name a few.

Jeffrey S. Grand, a partner at Bernstein Liebhard LLP is a Plaintiffs’ Steering Committee member for four federal transvaginal mesh proceedings alleging injuries caused by transvaginal mesh (pelvic mesh) implants in the U.S. District Court for the Southern District of West Virginia. These litigations have been created for claims involving products from the Johnson & Johnson subsidiary, Ethicon, Inc., as well as Boston Scientific Corp., American Medical Systems, Inc. and C.R. Bard, Inc.

Mr. Grand is also serving as Co-Liaison Counsel in a consolidated Ethicon mesh litigation underway in New Jersey’s Atlantic County Superior Court, for which he was on the trial team in the proceeding’s first trial earlier this year. The hearing of this transvaginal mesh lawsuit concluded in March 2013 with an $11 million damage award to the Plaintiff, whose injuries were found to be a result of the Ethicon Gynecare pelvic mesh implant she received.

Additionally, the Firm is investigating claims on behalf of individuals who may have developed pancreatitis, pancreatic cancer, or thyroid cancer following their use of Byetta, Januvia or another Type-2 diabetes medication part of a class known as incretin mimetics. While these drugs have not been recalled, the U.S. Food and Drug Administration (FDA) announced in March 2013 that it would be investigating the pancreatic side effects alleged in a growing number of federal and state-filed product liability and personal injury claims.

Bernstein Liebhard LLP is also representing hundreds of men and women who received the DePuy ASR hip replacement system, the Biomet M2a Magnum device and other metal-on-metal hip replacement devices that may now be causing them pain, swelling and other symptoms associated with metal ion poisoning. These implants, which are comprised of cobalt and chromium materials, have been at the center of scrutiny from the FDA for their association with excessively high early failure rates. The Stryker Rejuvenate and ABG II modular-neck hip stems were recalled on July 6, 2012 by their manufacturer, who estimates that 20,000 devices were sold in the U.S. prior to the recall.

In a federal DePuy ASR metal-on-metal hip litigation underway in the U.S. District Court, Northern District of Indiana, the attorneys at Bernstein Liebhard LLP are following the status of a historic DePuy ASR hip settlement that may resolve 8,000 cases alleging premature device failure complications. Felecia S. Stern, a partner at Bernstein Liebhard LLP was recently quoted in The National Law Journal about the Firm’s involvement in the agreement, which was introduced by Johnson & Johnson in November 2013.

Since 1993, Bernstein Liebhard LLP has represented individuals harmed by defective drugs, medical devices and consumer products. Among its list of professional accolades, the Firm was recently named to the National Law Journal’s “Plaintiffs’ Hot List’ for the 11th year in a row.

Last Modified: July 22, 2014

Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.

 
 
 

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest